Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[11C]5-Hydroxy-tryptophan Positron Emission Tomography for Assessment of Islet Mass During Progression of Type 2 Diabetes

NCT02967354 is registered in ClinicalTrials.gov with Per-Ola Carlsson as lead sponsor.

NCT NCT02967354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[11C]5-Hydroxy-tryptophan Positron Emission Tomography for Assessment of Islet Mass During Progression of Type 2 Diabetes
Lead sponsor
Per-Ola Carlsson
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
October 31, 2015
Enrollment
39 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes